Nihon Kohden (OTCMKTS:NHNKY) Sees Unusually-High Trading Volume – What’s Next?

Nihon Kohden Corporation (OTCMKTS:NHNKY – Get Free Report) shares saw unusually-strong trading volume on Monday . Approximately 190,420 shares changed hands during mid-day trading, an increase of 585% from the previous session’s volume of 27,797 shares.The stock last traded at $9.68 and had previously closed at $9.5750.

Wall Street Analysts Forecast Growth

Separately, Zacks Research upgraded Nihon Kohden to a “hold” rating in a research report on Monday, April 27th. One analyst has rated the stock with a Strong Buy rating and one has issued a Hold rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Buy”.

Get Nihon Kohden alerts:

Read Our Latest Analysis on NHNKY

Nihon Kohden Stock Performance

The firm has a market cap of $1.63 billion, a price-to-earnings ratio of 16.40 and a beta of 0.39. The stock’s fifty day moving average is $9.00 and its two-hundred day moving average is $9.92.

Nihon Kohden (OTCMKTS:NHNKY – Get Free Report) last posted its earnings results on Thursday, May 14th. The company reported $0.34 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.24 by $0.10. Nihon Kohden had a net margin of 6.08% and a return on equity of 9.46%. The firm had revenue of $453.10 million during the quarter, compared to analyst estimates of $414.40 million. Sell-side analysts predict that Nihon Kohden Corporation will post 0.6 earnings per share for the current year.

Nihon Kohden Company Profile

(Get Free Report)

Nihon Kohden Corporation is a Tokyo-based manufacturer of medical electronic equipment, founded in 1951. The company has built a reputation for innovation in patient monitoring and diagnostic systems, developing one of Japan’s earliest electrocardiogram (ECG) machines and pioneering transistor-based oscilloscopes for clinical use. Over the decades, Nihon Kohden has expanded its product portfolio to address a wide range of healthcare needs, from emergency response to intensive care and neurology.

The company’s core offerings include patient monitors, ECG and electroencephalograph (EEG) devices, defibrillators, infusion pumps, and neuromonitoring systems.

See Also

• Five stocks we like better than Nihon Kohden
• Is Domino’s Stock Serving Up a Buying Opportunity?
• A $1T Black Hole: SpaceX Eyes Pentagon AI to Break Free
• Why Gold Miners Could Be the Market’s Biggest Comeback Story
• Amazon’s AI Spending Is About to Face Its Most Important AWS Test Yet

Receive News & Ratings for Nihon Kohden Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nihon Kohden and related companies with MarketBeat.com's FREE daily email newsletter.